Policy

European Patent Office restricts patent that raised concerns over human genetic manipulation

Published in Blood Weekly, August 22nd, 2002

The European Patent Office has overturned central parts of a stem cell research patent granted to a Scottish university in 1999 that critics claimed would allow genetic manipulation of human organs and cells.

The German, Italian and Dutch governments, along with the environmental group Greenpeace, were among opponents who appealed against the University of Edinburgh's patent, titled "isolation, selection and propagation of animal transgenic stem cells."

The patent failed to make it clear that the approval doesn't apply to humans, although the Edinburgh researchers gave assurances that they never intended the patent to allow the creation of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2002-08-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry